Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Postal Realty Trust (PSTL) Q4 FFO Match Estimates
Postal Realty Trust (PSTL) Q4 FFO Match Estimates

Postal Realty Trust (PSTL) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.35 per share a year ago

LTC Properties (LTC) Tops Q4 FFO Estimates
LTC Properties (LTC) Tops Q4 FFO Estimates

LTC Properties (LTC) came out with quarterly funds from operations (FFO) of $0.7 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to FFO of $0.72 per share a year

Light & Wonder (LNWO) Surpasses Q4 Earnings Estimates
Light & Wonder (LNWO) Surpasses Q4 Earnings Estimates

Light & Wonder (LNWO) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.42 per share a year ago. These

Interparfums (IPAR) Beats Q4 Earnings and Revenue Estimates
Interparfums (IPAR) Beats Q4 Earnings and Revenue Estimates

Interparfums (IPAR) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.82 per share a year ago. These

Hyliion Holdings Corp. (HYLN) Reports Q4 Loss, Misses Revenue Estimates
Hyliion Holdings Corp. (HYLN) Reports Q4 Loss, Misses Revenue Estimates

Hyliion Holdings Corp. (HYLN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.08 per share a year ago. These

Luxfer (LXFR) Beats Q4 Earnings Estimates
Luxfer (LXFR) Beats Q4 Earnings Estimates

Luxfer (LXFR) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.29 per share a year ago. These figures are

FrontView REIT, Inc. (FVR) Meets Q4 FFO Estimates
FrontView REIT, Inc. (FVR) Meets Q4 FFO Estimates

FrontView REIT, Inc. (FVR) came out with quarterly funds from operations (FFO) of $0.31 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.27 per share a year ago

Everus Construction Group, Inc. (ECG) Q4 Earnings and Revenues Top Estimates
Everus Construction Group, Inc. (ECG) Q4 Earnings and Revenues Top Estimates

Everus Construction Group, Inc. (ECG) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.67 per share a

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Corcept Therapeutics (CORT) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago

Evolent Health (EVH) Q4 Earnings Top Estimates
Evolent Health (EVH) Q4 Earnings Top Estimates

Evolent Health (EVH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.02 per share a year ago. These

Globus Medical (GMED) Surpasses Q4 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Globus Medical (GMED) Surpasses Q4 Earnings and Revenue Estimates

Globus Medical (GMED) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.84 per share a year ago. These

Flywire (FLYW) Reports Break-Even Earnings for Q4
Flywire (FLYW) Reports Break-Even Earnings for Q4

Flywire (FLYW) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.12 per share a year ago. These figures are

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates

AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.11 per share a year ago. These

CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates

CeriBell, Inc. (CBLL) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago. These figures

Archrock Inc. (AROC) Q4 Earnings and Revenues Beat Estimates
Archrock Inc. (AROC) Q4 Earnings and Revenues Beat Estimates

Archrock Inc. (AROC) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.35 per share a year ago. These

Carlyle Secured Lending, Inc. (CGBD) Q4 Earnings and Revenues Miss Estimates
Carlyle Secured Lending, Inc. (CGBD) Q4 Earnings and Revenues Miss Estimates

Carlyle Secured Lending, Inc. (CGBD) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.47 per share a year

Slide Insurance Holdings, Inc. (SLDE) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Slide Insurance Holdings, Inc. (SLDE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Slide Insurance Holdings, Inc. (SLDE) reported $347.01 million in revenue for the quarter ended December 2025, representing no change year over year. EPS of $1.23 for the same period compares to $0

Resideo Technologies (REZI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Resideo Technologies (REZI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Resideo Technologies (REZI) reported $1.9 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 2%. EPS of $0.50 for the same period compares to $0.59 a

Merit Medical (MMSI) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Merit Medical (MMSI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2025, Merit Medical (MMSI) reported revenue of $393.94 million, up 10.9% over the same period last year. EPS came in at $1.04, compared to $0.93 in the year-ago

Compared to Estimates, Realty Income Corp. (O) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Realty Income Corp. (O) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2025, Realty Income Corp. (O) reported revenue of $1.49 billion, up 11% over the same period last year. EPS came in at $1.08, compared to $0.23 in the year-ago

Jazz (JAZZ) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Jazz (JAZZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2025, Jazz Pharmaceuticals (JAZZ) reported revenue of $1.2 billion, up 10.1% over the same period last year. EPS came in at $6.64, compared to $6.60 in the year-ago

Here's What Key Metrics Tell Us About Revolve Group (RVLV) Q4 Earnings
Here's What Key Metrics Tell Us About Revolve Group (RVLV) Q4 Earnings

For the quarter ended December 2025, Revolve Group (RVLV) reported revenue of $324.37 million, up 10.4% over the same period last year. EPS came in at $0.26, compared to $0.17 in the year-ago

CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say
CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2025, CareDx (CDNA) reported revenue of $108.39 million, up 25.2% over the same period last year. EPS came in at $0.12, compared to $0.18 in the year-ago quarter.

The

Compared to Estimates, Axon (AXON) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Axon (AXON) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2025, Axon Enterprise (AXON) reported revenue of $796.72 million, up 38.5% over the same period last year. EPS came in at $2.15, compared to $2.08 in the year-ago

Compared to Estimates, Cava (CAVA) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Cava (CAVA) Q4 Earnings: A Look at Key Metrics

Cava Group (CAVA) reported $274.99 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 20.9%. EPS of $0.04 for the same period compares to $0.05 a year